Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Long-Term Outcomes of Pulmonary Embolism Requiring Intensive Care Unit (ICU) Admission

Brian T Grainger, Eldho Paul, Vinodh Nanjayya, Huyen Tran, David Pilcher, James D McFadyen

Blood (2023) 142 (Supplement 1): 1271.

https://doi.org/10.1182/blood-2023-187813

Published: 2023

Journal Articles

Efficacy and Safety of Concizumab Prophylaxis in Patients with Hemophilia A or B without Inhibitors: 56-Week Cut-Off Results of the Phase 3 explorer8 Study

Jan Astermark, Shashikant Apte, Chuhl Joo Lyu, Amalie Rhode Høgh Nielsen, Sonata Saulyte Trakymiene, Jay Jay Thaung Zaw, Huyen Tran, Jerzy Windyga, Hermann Eichler

Blood (2023) 142 (Supplement 1): 2609.

https://doi.org/10.1182/blood-2023-173118

Published: 2023

Journal Articles

Rapid Clearance of Vector Following AAV-Mediated FVIII Gene Transfer in the Phase I/II Trial of SPK-8011 in People with Hemophilia A

Huyen Tran, M. Elaine Eyster, Stacy E. Croteau, Margaret V. Ragni, Benjamin J. Samelson-Jones, Spencer Sullivan, John E.J. Rasko, Kristen Jaworski, Amy MacDougall, Savina Jaeger, Magdalena Hofer, Charlie Li, Federico Mingozzi, Tiffany Chang, Gallia Levy

Blood (2022) 140 (Supplement 1): 10662–10664.

https://doi.org/10.1182/blood-2022-159027

Published: 2022

Journal Articles

The Effects of Immunomodulation with Corticosteroids to Manage an AAV Capsid Immune response in the Phase I/II Study of SPK-8011

Matthew S. Evans, Witold B. Rybka, Stacy E. Croteau, Huyen Tran, John E.J. Rasko, Kristen Jaworski, Amy MacDougall, Savina Jaeger, Federico Mingozzi, Tiffany Chang, Gallia Levy

Blood (2022) 140 (Supplement 1): 10654–10655.

https://doi.org/10.1182/blood-2022-159017

Published: 2022

Journal Articles

Health-Related Quality of Life in Patients with Hemophilia A or B with Inhibitors on Concizumab Prophylaxis: Results from the Phase 3 explorer7 Study

Amy D. Shapiro, Aby Abraham, Silvia Linari, Jesper Skov Neergaard, Jan Odgaard-Jensen, Jay Jay Thaung Zaw, Huyen Tran

Blood (2022) 140 (Supplement 1): 2732–2734.

https://doi.org/10.1182/blood-2022-166306

Published: 2022

Journal Articles

The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia

Huyen Tran, Lucy Deng, Nicholas Wood, Vivien M Chen

Blood (2022) 140 (Supplement 1): 5654–5655.

https://doi.org/10.1182/blood-2022-168844

Published: 2022

Journal Articles

Long-Term Durable FVIII Expression with Improvements in Bleeding Rates Following AAV-Mediated FVIII Gene Transfer for Hemophilia A: Multiyear Follow-up on the Phase I/II Trial of SPK-8011

Blood (2022) 140 (Supplement 1): 1899–1901.

https://doi.org/10.1182/blood-2022-158903

Published: 2022

Journal Articles

Endothelial Cell Activation Enhances Thromboinflammation in Vitt

Alexander Dupuy, Xiaoming Liu, Jessica Tieng, Bede Johnston, Arian Nasser, Paul Coleman, Yingqi Zhang, Lining Arnold Ju, Huyen Tran, Vivien M Chen, Elizabeth E. Gardiner, Freda H. Passam

Blood (2022) 140 (Supplement 1): 1656–1657.

https://doi.org/10.1182/blood-2022-168441

Published: 2022

Journal Articles

Anticoagulation and Antiplatelet Strategies in Non-Critically Ill Patients with Covid-19

Zoe McQuilten, Balasubramanian Venkatesh, Vivekanand Jha, Jason Roberts, Susan Morpeth, James Totterdell, Grace McPhee, John Abraham, Niraj Bam, Methma Bandara, Ashpak Bangi, Lauren Barina, Bhupendra Basnet, Hasan Bhally, Khemr Bhusal, Umesh Bogati, Asha Bowen, Andrew Burke, Devasahayam Christopher, Sanjeev Chunilal, Belinda Cochrane, Jennifer Curnow, Varaprasad Babu Dara Reddy, Santa Das, Ashesh Dhungana, Gian Luca Di Tanna, Ravindra Dotel, Hyjel DSouza, Jack Dummer, Sourabh Dutta, Hong Foo, Timothy Gilbey, Michelle Giles, Kasiram Goli, Adrienne Gordon, Pradip Gyanwali, Bernard Hudson, Manoj Jani, Purnima Jevaji, Sachin Jhawar, Aikaj Jindal, M. Joseph John, Mary John, Flavita John, Oommen John, Mark Jones, Rajesh Joshi, Prashanthi Kamath, Gagandeep Kang, Achyut Karki, Abhishek Karmalkar, Baldeep Kaur, Kalyan Chakravarthy Koganti, Jency Koshy, S K Mathew, Jilllian Lau, Sharon Lewin, Lyn-li Lim, Ian Marschner, Julie Marsh, Michael Maze, James McGree, James McMahon, Robert Medcalf, Eileen Merriman, Amol Misal, Jocelyn Mora, Vijaybabu Mudaliar, Vi Nguyen, Matthew O'Sullivan, Suman Pant, Pankaj Pant, David Paterson, David Price, Megan Rees, James Owen Robinson, Benjamin Rogers, Sandhya Samuel, Joe Sasadeusz, Deepak Sharma, Prabhat Sharma, Roshan Shrestha, Sailesh Shrestha, Prajowl Shrestha, Urvi Shukla, Omar Shum, Christine Sommerville, Tim Spelman, Richard Sullivan, Umashankar Thatavarthi, Huyen Tran, Nanette Trask, Claire Whitehead, Robert Mahar, Naomi Hammond, James David McFadyen, Thomas Snelling, Joshua Davis, Justin Denholm, Steven YC Tong

Blood (2022) 140 (Supplement 1): 326–328.

https://doi.org/10.1182/blood-2022-168448

Published: 2022

Journal Articles

Inherited Thrombophilias Are Associated with an Increased Risk of COVID-19 Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study

Hannah P Stevens, Rodrigo Canovas, Karlheinz Peter, Huyen Tran, Zane Kaplan, James David McFadyen

Blood (2021) 138 (Supplement 1): 3214.

https://doi.org/10.1182/blood-2021-149841

Published: 2021

Journal Articles

Efficacy and Safety of Fitusiran Prophylaxis, an siRNA Therapeutic, in a Multicenter Phase 3 Study (ATLAS-INH) in People with Hemophilia A or B, with Inhibitors (PwHI)

Guy Young, Alok Srivastava, Kaan Kavakli, Cecil Ross, Jameela Sathar, Huyen Tran, Runhui Wu, Jing Sun, Stacey Poloskey, Zhiying Qui, Salim Kichou, Shauna R. Andersson, Baisong Mei, Savita Rangarajan

Blood (2021) 138 (Supplement 1): 4.

https://doi.org/10.1182/blood-2021-150273

Published: 2021

Journal Articles

Low-Dose Heparin in Critically Ill Patients Undergoing Extracorporeal Membrane Oxygenation - the Help-ECMO Pilot Randomised Controlled Trial

Zoe McQuilten, Cecile Aubron, Michael Bailey, Jasmin Board, Heidi Buhr, Mark Dennis, Paul Forrest, David McIlroy, Lynnette Murray, Deirdre Murphy, Vincent Pellegrino, David Pilcher, Jayne Sheldrake, Huyen Tran, MD, Shirley Vallance, David Jamie Cooper

Blood (2016) 128 (22): 3822.

https://doi.org/10.1182/blood.V128.22.3822.3822

Published: 2016

Journal Articles

A Shear Micro-Gradient Microfluidic to Monitor Platelet Aggregation Dynamics in the Context of Von Willebrand Disease

Harshal Nandurkar, MD PhD FRACP, FRCPA, Warwick Nesbitt, PhD, Rose Brazilek, Francisco Tovar-Lopez, PhD, Angus Wong, Huyen Tran, MD FRACP, FRCPA, Amanda Davis, MD FRACP, FRCPA, Arnan Mitchell, PhD

Blood (2016) 128 (22): 3753.

https://doi.org/10.1182/blood.V128.22.3753.3753

Published: 2016

Journal Articles

Bortezomib Yields High Response Rates in Antibody-Mediated Autoimmune Hematological Diseases Refractory to Conventional Immunosuppression

Sumita Ratnasingam, MBBS, Patricia A. Walker, MBBS, Huy Tran, MBBS, Zane Kaplan, MD, James David McFadyen, MD, Huyen Tran, MD, Tse-Chieh Teh, MD, Erica M. Wood, MD, John V. Catalano, MD, Stephen Opat, MBBS, Jake Shortt, MD

Blood (2015) 126 (23): 3457.

https://doi.org/10.1182/blood.V126.23.3457.3457

Published: 2015

Journal Articles

Thrombin Generation and Venous Thromboembolism Among Multiple Myeloma Patients Receiving Lenalidomide and Prednisolone Maintenance Following Autologous Stem Cell Transplantation (ASCT)

Huyen Tran, MBBS, MSc, James David McFadyen, MD, Anna Kalff, MBBS, Andrew Spencer, MD

Blood (2014) 124 (21): 5072.

https://doi.org/10.1182/blood.V124.21.5072.5072

Published: 2014

Journal Articles

A Multi-Centre, Single-Arm, Open-Label Study Evaluating the Safety and Efficacy of Fixed Dose Rituximab in Patients with Refractory, Relapsing or Chronic Idiopathic Thrombocytopenic Purpura (R-ITP1000 Study) and Exploring Rituximab Response with the FcGammaR3A Polymorphisms

Huyen Tran, MBBS, MSc, FRACP, FRCPA, Jamie P Nourse, PhD, Rod Lea, PhD, Timothy A. Brighton, FRCPA, FRACP, MB, BS, MS, Andrew Grigg, MBBS, FRACP, FRCPA, Simon McRae, BMedSc, MBBS, FRACP, FRCPA, Daniel Thurley, MA, MB, BCHIR, Dep. pharm. med, MRCP, FFPM, Maher Gandhi, PhD, FRACP, FRCPath, FRCP, John Catalano, MBBS FRACP FRCPA

Blood (2011) 118 (21): 1157.

https://doi.org/10.1182/blood.V118.21.1157.1157

Published: 2011

NARROW

Long-Term Outcomes of Pulmonary Embolism Requiring Intensive Care Unit (ICU) Admission

Efficacy and Safety of Concizumab Prophylaxis in Patients with Hemophilia A or B without Inhibitors: 56-Week Cut-Off Results of the Phase 3 explorer8 Study

Rapid Clearance of Vector Following AAV-Mediated FVIII Gene Transfer in the Phase I/II Trial of SPK-8011 in People with Hemophilia A

The Effects of Immunomodulation with Corticosteroids to Manage an AAV Capsid Immune response in the Phase I/II Study of SPK-8011

Health-Related Quality of Life in Patients with Hemophilia A or B with Inhibitors on Concizumab Prophylaxis: Results from the Phase 3 explorer7 Study

The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia

Long-Term Durable FVIII Expression with Improvements in Bleeding Rates Following AAV-Mediated FVIII Gene Transfer for Hemophilia A: Multiyear Follow-up on the Phase I/II Trial of SPK-8011

Endothelial Cell Activation Enhances Thromboinflammation in Vitt

Anticoagulation and Antiplatelet Strategies in Non-Critically Ill Patients with Covid-19

Inherited Thrombophilias Are Associated with an Increased Risk of COVID-19 Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study

Efficacy and Safety of Fitusiran Prophylaxis, an siRNA Therapeutic, in a Multicenter Phase 3 Study (ATLAS-INH) in People with Hemophilia A or B, with Inhibitors (PwHI)

Low-Dose Heparin in Critically Ill Patients Undergoing Extracorporeal Membrane Oxygenation - the Help-ECMO Pilot Randomised Controlled Trial

A Shear Micro-Gradient Microfluidic to Monitor Platelet Aggregation Dynamics in the Context of Von Willebrand Disease

Bortezomib Yields High Response Rates in Antibody-Mediated Autoimmune Hematological Diseases Refractory to Conventional Immunosuppression

Thrombin Generation and Venous Thromboembolism Among Multiple Myeloma Patients Receiving Lenalidomide and Prednisolone Maintenance Following Autologous Stem Cell Transplantation (ASCT)

A Multi-Centre, Single-Arm, Open-Label Study Evaluating the Safety and Efficacy of Fixed Dose Rituximab in Patients with Refractory, Relapsing or Chronic Idiopathic Thrombocytopenic Purpura (R-ITP1000 Study) and Exploring Rituximab Response with the FcGammaR3A Polymorphisms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only